Policy Briefing
AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal
AstraZeneca has become the second major pharmaceutical manufacturer to sign a “most favored nation” pricing agreement with the Trump administration, committing to match the lowest drug prices offered in developed nations for Medicaid programs and newly launched products. President Donald
13 October 2025